Sichuan Cancer Hospital And Research Institute
Clinical trials sponsored by Sichuan Cancer Hospital And Research Institute, explained in plain language.
-
Triple therapy aims to turn inoperable lung cancer into a surgical target
Disease control Not yet recruitingThis study tests whether combining an immunotherapy drug (tislelizumab) with standard chemotherapy and a targeted artery treatment can shrink stage III lung cancer that cannot be removed by surgery. About 39 adults with newly diagnosed, unresectable non-small cell lung cancer wil…
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Ancient exercise tested to ease life after cancer surgery
Symptom relief Not yet recruitingThis study aims to see if a specially adapted version of Baduanjin, a traditional Chinese exercise, is safe and helpful for people living with a stoma after colorectal cancer surgery. Researchers will compare the gentle Baduanjin movements to regular walking over 12 weeks. They w…
Phase: NA • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Symptom relief
Last updated Apr 20, 2026 16:16 UTC
-
New MRI technique could predict rectal cancer spread before surgery
Knowledge-focused Not yet recruitingThis study tests whether a special MRI technique (IVIM) can predict lymphovascular invasion (LVI) in rectal cancer before surgery. LVI is a key sign that cancer may spread, but current tests often miss it. Researchers will scan 400 patients and compare MRI results with tissue sam…
Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Knowledge-focused
Last updated May 17, 2026 03:27 UTC